NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 68.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 16.09M | 14.21M | 11.61M | 4.45M | 6.46M | |||
Research and Development | 7.44M | 5.97M | 2.82M | 2.77M | 4.03M | |||
Selling, General, and Administrative Expenses | 8.64M | 8.24M | 6.60M | 1.68M | 2.43M | |||
Operating Income | -16.02M | -14.21M | -11.61M | -4.45M | -6.46M | |||
Interest Income/Expense | -2.15M | -536.00K | -1.23M | -240.00K | -3.31M | |||
Other Income/Expense | -12.12M | -6.54M | -10.17M | 90.00K | 160.00K | |||
Non Recurring Items | N/A | -4.95M | N/A | 0.00 | 6.35M | |||
Income Before Taxes | -30.29M | -26.23M | -23.01M | -4.60M | -3.27M | |||
Income Tax | -2.00K | 0.00 | 0.00 | 0.00 | 10.00K | |||
Net Income | -30.29M | -26.23M | -23.01M | -4.60M | -3.28M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -13.25 | -30.26 | -1.81 | -0.36 | -0.26 | |||
Non GAAP EPS | -12.38 | N/A | N/A | N/A | N/A | |||
Statistics | ||||||||
Profit Margin | -44538.24% | N/A | N/A | N/A | N/A | |||
Operating Profit Margin | -23555.88% | N/A | N/A | N/A | N/A |
All data in USD